ProPhase Labs (PRPH)
(Delayed Data from NSDQ)
$2.69 USD
+0.29 (12.08%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $2.69 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum F VGM
Price, Consensus and EPS Surprise
PRPH 2.69 +0.29(12.08%)
Will PRPH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PRPH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PRPH
Xenetic Biosciences (XBIO) Reports Q2 Loss, Tops Revenue Estimates
Eli Lilly (LLY) Surpasses Q2 Earnings and Revenue Estimates
PRPH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ionis Pharmaceuticals (IONS) Reports Q1 Loss, Misses Revenue Estimates
Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Tops Revenue Estimates
ProPhase Labs, Inc. (PRPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Other News for PRPH
ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event
ProPhase Labs Inc (PRPH) Q2 2024 Earnings Call Transcript Highlights: Strategic Growth and ...
PRPH Stock Earnings: ProPhase Labs Misses EPS, Misses Revenue for Q2 2024
ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2024
ProPhase Labs misses Q2 estimates